Allergen Immunotherapy in Autoimmune Terrain: A Case Study

Area of Science:

• Immunology
• Endocrinology
• Clinical Pharmacology

Background:

• Allergen immunotherapy (AIT) induces immune tolerance for allergic diseases but its use in autoimmune conditions is debated.
• Concerns exist regarding AIT potentially triggering or worsening autoimmune diseases.
• Managing patients with both allergic and autoimmune conditions requires careful consideration.

Purpose of the Study:

• To examine a case of autoimmune hypothyroidism developing during AIT.
• To evaluate management decisions for a patient with coexisting allergic rhinitis and newly diagnosed hypothyroidism.
• To assess the risk-benefit profile of continuing AIT in this context.

Main Methods:

• A case report of a 26-year-old female patient undergoing AIT for allergic rhinitis.
• Monitoring of thyroid function tests (TSH, anti-TPO antibodies) during AIT.
• Causality assessment for AIT-induced hypothyroidism and risk-benefit analysis for treatment continuation.

Main Results:

• The patient developed hypothyroidism with elevated TSH and positive anti-TPO antibodies three months into AIT.
• A "possible" link was identified between AIT and the onset of hypothyroidism.
• Continuation of AIT alongside L-thyroxine therapy led to normalized TSH and improved allergic rhinitis symptoms.

Conclusions:

• AIT can be continued in patients who develop hypothyroidism, provided it is managed with hormone replacement therapy.
• Personalized risk-benefit analysis is crucial for managing patients with coexisting allergic and autoimmune diseases.
• Understanding immune modulation (e.g., Th17/Treg balance, neutrophils) is key for optimizing AIT in complex cases.